CROTTI, CHIARA
CROTTI, CHIARA
Universita' degli Studi di MILANO
A novel mutation in collagen gene COL1A2 associated with transient regional osteoporosis
2022 M. Varenna, C. Crotti, M.T. Bonati, F. Zucchi, M. Gallazzi, R. Caporali
A review of the literature analyzing benefits and concerns of infliximab biosimilar CT-P13 for the treatment of rheumatologic diseases: Focus on interchangeability
2017 A. Becciolini, M.G. Raimondo, C. Crotti, E. Agape, M. Biggioggero, E.G. Favalli
Acute phase reactions after zoledronic acid infusion: protective role of 25-OH vitamin D and previous oral bisphosphonate therapy
2018 C. Crotti, N.B. Watts, M. De Santis, A. Ceribelli, G. Fabbriciani, F. Cavaciocchi, B. Marasini, C. Selmi, M. Massarotti
Antiphospholipid antibody mechanisms of thrombosis
2015 P.L. Meroni, C. Crotti, C. Chighizola
Decreasing severity of Paget's disease of bone in northern Italy over the last two decades: results of a monocentric study on 391 patients
2021 M. Varenna, F. Zucchi, C. Crotti, M. Manara, R. Caporali
Effectiveness and safety of oxycodone/naloxone in the management of chronic pain in patients with systemic sclerosis with recurrent digital ulcers : Two case reports
2016 N. Ughi, C. Crotti, F. Ingegnoli
Gamma-delta T lymphocytes and 25-hydroxy vitamin D levels as key factors in autoimmunity and inflammation : the case of zoledronic acid-induced acute phase reaction
2015 M. De Santis, F. Cavaciocchi, A. Ceribelli, C. Crotti, E. Generali, G. Fabbriciani, C. Selmi, M. Massarotti
Genome-wide analysis of DNA methylation, copy number variation, and gene expression in monozygotic twins discordant for primary biliary cirrhosis
2014 C. Selmi, F. Cavaciocchi, A. Lleo, C. Cheroni, R. De Francesco, S.A. Lombardi, M. De Santis, F. Meda, M.G. Raimondo, C. Crotti, M. Folci, L. Zammataro, M.J. Mayo, N. Bach, S. Shimoda, S.C. Gordon, M. Miozzo, P. Invernizzi, M. Podda, R. Scavelli, M.R. Martin, J.M. Lasalle, M.E. Gershwin
Glutamic acid decarboxylase antibody
2013 C. Crotti, C. Selmi
Less travelled roads in clinical immunology and allergy : drug reactions and the environmental influence
2013 C. Selmi, C. Crotti, P.L. Meroni
Liver abnormalities in connective tissue diseases
2013 M. De Santis, C. Crotti, C. Selmi
Long-term use of burosumab for the treatment of tumor-induced osteomalacia
2023 C. Crotti, F. Zucchi, C. Alfieri, R. Caporali, M. Varenna
Nailfold scleroderma-like capillary abnormalities in Werner syndrome (adult progeria)
2017 F. Ingegnoli, C. Crotti
Outcomes, rates and predictors of transition of isolated Raynaud's phenomenon : a systematic review and meta-analysis
2017 F. Ingegnoli, N. Ughi, C. Crotti, M. Mosca, C. Tani
Outcomes, rates, and risk factors of transition of Raynaud's phenomenon to a connective tissue disease: systematic review and meta-analysis
2016 N. Ughi, F. Ingegnoli, C. Crotti, M. Mosca, C. Tani
Real-life 10-year retention rate of first-line anti-TNF drugs for inflammatory arthritides in adult- and juvenile-onset populations : similarities and differences
2017 E.G. Favalli, I. Pontikaki, A. Becciolini, M. Biggioggero, N. Ughi, M. Romano, C. Crotti, M. Gattinara, V. Gerloni, A. Marchesoni, P.L. Meroni
Sarilumab : patient-reported outcomes in rheumatoid arthritis
2018 C. Crotti, M. Biggioggero, A. Becciolini, E.G. Favalli
Sex and Management of Rheumatoid Arthritis
2019 E.G. Favalli, M. Biggioggero, C. Crotti, A. Becciolini, M.G. Raimondo, P.L. Meroni
Spotlight on mavrilimumab for the treatment of rheumatoid arthritis : Evidence to date
2017 C. Crotti, M.G. Raimondo, A. Becciolini, M. Biggioggero, E.G. Favalli
Targeting Granulocyte-Monocyte Colony-Stimulating Factor Signaling in Rheumatoid Arthritis: Future Prospects
2019 C. Crotti, E. Agape, A. Becciolini, M. Biggioggero, E.G. Favalli